nodes	percent_of_prediction	percent_of_DWPC	metapath
Entacapone—COMT—breast cancer	0.566	1	CbGaD
Entacapone—UGT1A9—Irinotecan—breast cancer	0.0836	1	CbGbCtD
Entacapone—Tolcapone—COMT—breast cancer	0.00389	1	CrCbGaD
Entacapone—COMT—nipple—breast cancer	0.000968	0.137	CbGeAlD
Entacapone—UGT1A9—endocrine gland—breast cancer	0.000748	0.106	CbGeAlD
Entacapone—COMT—skin of body—breast cancer	0.00062	0.0878	CbGeAlD
Entacapone—COMT—endometrium—breast cancer	0.000584	0.0827	CbGeAlD
Entacapone—COMT—uterus—breast cancer	0.000539	0.0763	CbGeAlD
Entacapone—COMT—pituitary gland—breast cancer	0.000529	0.0749	CbGeAlD
Entacapone—COMT—adipose tissue—breast cancer	0.000527	0.0746	CbGeAlD
Entacapone—COMT—female reproductive system—breast cancer	0.000484	0.0685	CbGeAlD
Entacapone—COMT—adrenal gland—breast cancer	0.000472	0.0669	CbGeAlD
Entacapone—COMT—bone marrow—breast cancer	0.000457	0.0647	CbGeAlD
Entacapone—COMT—female gonad—breast cancer	0.000441	0.0624	CbGeAlD
Entacapone—COMT—endocrine gland—breast cancer	0.00041	0.058	CbGeAlD
Entacapone—COMT—lymph node—breast cancer	0.000283	0.0401	CbGeAlD
Entacapone—UGT1A9—NRF2 pathway—EGR1—breast cancer	0.000128	0.00131	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA2—breast cancer	0.000127	0.00129	CbGpPWpGaD
Entacapone—UGT1A9—PPARA activates gene expression—CYP1A1—breast cancer	0.000126	0.00128	CbGpPWpGaD
Entacapone—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—breast cancer	0.000123	0.00126	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—breast cancer	0.000123	0.00125	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—SRC—breast cancer	0.000121	0.00124	CbGpPWpGaD
Entacapone—COMT—Metabolism—SYNJ2—breast cancer	0.000118	0.00121	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP3A4—breast cancer	0.000118	0.0012	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP3A4—breast cancer	0.000116	0.00119	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1B1—breast cancer	0.000116	0.00118	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	0.000116	0.00118	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFBR2—breast cancer	0.000115	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTP1—breast cancer	0.000115	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1B1—breast cancer	0.000114	0.00117	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HMOX1—breast cancer	0.000113	0.00116	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—NCOA1—breast cancer	0.000111	0.00113	CbGpPWpGaD
Entacapone—COMT—Metabolism—NDUFS3—breast cancer	0.00011	0.00112	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP19A1—breast cancer	0.000109	0.00111	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	0.000109	0.00111	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP19A1—breast cancer	0.000108	0.0011	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOA1—breast cancer	0.000107	0.00109	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	0.000106	0.00109	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—GSTM1—breast cancer	0.000106	0.00108	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—HGF—breast cancer	0.000106	0.00108	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	0.000105	0.00107	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	0.000105	0.00107	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—NRG1—breast cancer	0.000104	0.00106	CbGpPWpGaD
Entacapone—COMT—Metabolism—CHST9—breast cancer	0.000103	0.00105	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—COMT—breast cancer	0.000101	0.00104	CbGpPWpGaD
Entacapone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	0.000101	0.00104	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTP1—breast cancer	0.000101	0.00103	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—COMT—breast cancer	0.0001	0.00102	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HADHB—breast cancer	9.97e-05	0.00102	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTP1—breast cancer	9.95e-05	0.00102	CbGpPWpGaD
Entacapone—COMT—Metabolism—COX11—breast cancer	9.78e-05	0.000999	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—BRAF—breast cancer	9.57e-05	0.000978	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—GSTM1—breast cancer	9.27e-05	0.000947	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—GSTM1—breast cancer	9.14e-05	0.000934	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FHL2—breast cancer	9.12e-05	0.000931	CbGpPWpGaD
Entacapone—COMT—Metabolism—SHMT1—breast cancer	8.94e-05	0.000914	CbGpPWpGaD
Entacapone—COMT—Metabolism—CDA—breast cancer	8.94e-05	0.000914	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—NCOR1—breast cancer	8.94e-05	0.000913	CbGpPWpGaD
Entacapone—UGT1A9—Biological oxidations—CYP1A1—breast cancer	8.79e-05	0.000898	CbGpPWpGaD
Entacapone—UGT1A9—Metapathway biotransformation—CYP1A1—breast cancer	8.67e-05	0.000885	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLCO1B1—breast cancer	8.61e-05	0.00088	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC2A5—breast cancer	8.61e-05	0.00088	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	8.48e-05	0.000866	CbGpPWpGaD
Entacapone—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—breast cancer	8.47e-05	0.000866	CbGpPWpGaD
Entacapone—COMT—Metabolism—APRT—breast cancer	8.31e-05	0.000849	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	8.21e-05	0.000839	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—MDM2—breast cancer	8.02e-05	0.000819	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—RAF1—breast cancer	7.99e-05	0.000817	CbGpPWpGaD
Entacapone—COMT—Metabolism—ANGPTL4—breast cancer	7.82e-05	0.000799	CbGpPWpGaD
Entacapone—COMT—Metabolism—ESRRA—breast cancer	7.82e-05	0.000799	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPX2—breast cancer	7.55e-05	0.000772	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPX4—breast cancer	7.46e-05	0.000762	CbGpPWpGaD
Entacapone—COMT—Metabolism—HADHB—breast cancer	7.41e-05	0.000757	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPI—breast cancer	7.41e-05	0.000757	CbGpPWpGaD
Entacapone—COMT—Neuronal System—BRAF—breast cancer	7.33e-05	0.000749	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—IDH1—breast cancer	7.29e-05	0.000745	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SYNJ2—breast cancer	7.07e-05	0.000722	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALDH7A1—breast cancer	7.07e-05	0.000722	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALDH1A1—breast cancer	7.07e-05	0.000722	CbGpPWpGaD
Entacapone—COMT—Metabolism—PHGDH—breast cancer	6.78e-05	0.000692	CbGpPWpGaD
Entacapone—COMT—Metabolism—FHL2—breast cancer	6.78e-05	0.000692	CbGpPWpGaD
Entacapone—COMT—Metabolism—ADSL—breast cancer	6.78e-05	0.000692	CbGpPWpGaD
Entacapone—COMT—Metabolism—NME1—breast cancer	6.78e-05	0.000692	CbGpPWpGaD
Entacapone—COMT—Metabolism—UMPS—breast cancer	6.78e-05	0.000692	CbGpPWpGaD
Entacapone—COMT—Metabolism—LDHB—breast cancer	6.65e-05	0.000679	CbGpPWpGaD
Entacapone—COMT—Metabolism—BRIP1—breast cancer	6.65e-05	0.000679	CbGpPWpGaD
Entacapone—COMT—Metabolism—HPSE—breast cancer	6.65e-05	0.000679	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NDUFS3—breast cancer	6.57e-05	0.000671	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—MED12—breast cancer	6.32e-05	0.000646	CbGpPWpGaD
Entacapone—COMT—Metabolism—HMMR—breast cancer	6.3e-05	0.000644	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA3—breast cancer	6.3e-05	0.000644	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCC1—breast cancer	6.3e-05	0.000644	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CHST9—breast cancer	6.18e-05	0.000631	CbGpPWpGaD
Entacapone—COMT—Neuronal System—MDM2—breast cancer	6.14e-05	0.000628	CbGpPWpGaD
Entacapone—COMT—Neuronal System—RAF1—breast cancer	6.12e-05	0.000626	CbGpPWpGaD
Entacapone—COMT—Metabolism—PPARGC1B—breast cancer	6.1e-05	0.000623	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	6.04e-05	0.000617	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	5.88e-05	0.0006	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—COX11—breast cancer	5.86e-05	0.000598	CbGpPWpGaD
Entacapone—COMT—Metabolism—CA9—breast cancer	5.76e-05	0.000589	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA4—breast cancer	5.76e-05	0.000589	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	5.76e-05	0.000589	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPX2—breast cancer	5.62e-05	0.000574	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA2—breast cancer	5.62e-05	0.000574	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ACHE—breast cancer	5.59e-05	0.000571	CbGpPWpGaD
Entacapone—COMT—Metabolism—GPX4—breast cancer	5.55e-05	0.000567	CbGpPWpGaD
Entacapone—COMT—Metabolism—SULT1A1—breast cancer	5.55e-05	0.000567	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTA1—breast cancer	5.42e-05	0.000554	CbGpPWpGaD
Entacapone—COMT—Metabolism—IDH1—breast cancer	5.42e-05	0.000554	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SHMT1—breast cancer	5.36e-05	0.000547	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CDA—breast cancer	5.36e-05	0.000547	CbGpPWpGaD
Entacapone—COMT—Metabolism—NAT2—breast cancer	5.36e-05	0.000547	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	5.29e-05	0.00054	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	5.24e-05	0.000535	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC2A5—breast cancer	5.16e-05	0.000527	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLCO1B1—breast cancer	5.16e-05	0.000527	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	5.04e-05	0.000515	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—APRT—breast cancer	4.98e-05	0.000509	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—FASN—breast cancer	4.89e-05	0.000499	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—breast cancer	4.87e-05	0.000497	CbGpPWpGaD
Entacapone—COMT—Metabolism—MED12—breast cancer	4.7e-05	0.00048	CbGpPWpGaD
Entacapone—COMT—Metabolism—DPYD—breast cancer	4.7e-05	0.00048	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ANGPTL4—breast cancer	4.68e-05	0.000478	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ESRRA—breast cancer	4.68e-05	0.000478	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALDOA—breast cancer	4.62e-05	0.000472	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOA3—breast cancer	4.49e-05	0.000459	CbGpPWpGaD
Entacapone—COMT—Metabolism—SLC2A2—breast cancer	4.46e-05	0.000455	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	4.45e-05	0.000455	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPI—breast cancer	4.44e-05	0.000454	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HADHB—breast cancer	4.44e-05	0.000454	CbGpPWpGaD
Entacapone—COMT—Transmission across Chemical Synapses—HRAS—breast cancer	4.4e-05	0.00045	CbGpPWpGaD
Entacapone—COMT—Metabolism—CPT1A—breast cancer	4.37e-05	0.000446	CbGpPWpGaD
Entacapone—COMT—Metabolism—MTR—breast cancer	4.37e-05	0.000446	CbGpPWpGaD
Entacapone—COMT—Metabolism—ABCG2—breast cancer	4.37e-05	0.000446	CbGpPWpGaD
Entacapone—UGT1A9—NRF2 pathway—TGFB1—breast cancer	4.31e-05	0.00044	CbGpPWpGaD
Entacapone—COMT—Metabolism—HPGDS—breast cancer	4.28e-05	0.000438	CbGpPWpGaD
Entacapone—COMT—Metabolism—HBA1—breast cancer	4.26e-05	0.000435	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	4.25e-05	0.000434	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALDH1A1—breast cancer	4.24e-05	0.000433	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALDH7A1—breast cancer	4.24e-05	0.000433	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	4.19e-05	0.000428	CbGpPWpGaD
Entacapone—COMT—Metabolism—ACHE—breast cancer	4.15e-05	0.000424	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTT1—breast cancer	4.15e-05	0.000424	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PHGDH—breast cancer	4.06e-05	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—FHL2—breast cancer	4.06e-05	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NME1—breast cancer	4.06e-05	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ADSL—breast cancer	4.06e-05	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—UMPS—breast cancer	4.06e-05	0.000415	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HPSE—breast cancer	3.98e-05	0.000407	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—LDHB—breast cancer	3.98e-05	0.000407	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BRIP1—breast cancer	3.98e-05	0.000407	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP17A1—breast cancer	3.93e-05	0.000402	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS1—breast cancer	3.89e-05	0.000398	CbGpPWpGaD
Entacapone—COMT—Metabolism—ENO1—breast cancer	3.89e-05	0.000398	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP2D6—breast cancer	3.82e-05	0.00039	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ABCC1—breast cancer	3.77e-05	0.000386	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA3—breast cancer	3.77e-05	0.000386	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HMMR—breast cancer	3.77e-05	0.000386	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOA2—breast cancer	3.75e-05	0.000383	CbGpPWpGaD
Entacapone—Dermatitis—Gemcitabine—breast cancer	3.66e-05	0.000152	CcSEcCtD
Entacapone—Eye disorder—Epirubicin—breast cancer	3.66e-05	0.000151	CcSEcCtD
Entacapone—UGT1A9—Metabolism—PPARGC1B—breast cancer	3.66e-05	0.000373	CbGpPWpGaD
Entacapone—Malnutrition—Methotrexate—breast cancer	3.64e-05	0.000151	CcSEcCtD
Entacapone—Haemoglobin—Doxorubicin—breast cancer	3.64e-05	0.000151	CcSEcCtD
Entacapone—Headache—Gemcitabine—breast cancer	3.64e-05	0.000151	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Capecitabine—breast cancer	3.64e-05	0.000151	CcSEcCtD
Entacapone—Flushing—Epirubicin—breast cancer	3.64e-05	0.00015	CcSEcCtD
Entacapone—Cardiac disorder—Epirubicin—breast cancer	3.64e-05	0.00015	CcSEcCtD
Entacapone—Vomiting—Fluorouracil—breast cancer	3.63e-05	0.00015	CcSEcCtD
Entacapone—COMT—Metabolism—FASN—breast cancer	3.63e-05	0.000371	CbGpPWpGaD
Entacapone—Dyspepsia—Docetaxel—breast cancer	3.63e-05	0.00015	CcSEcCtD
Entacapone—Hepatitis—Doxorubicin—breast cancer	3.62e-05	0.00015	CcSEcCtD
Entacapone—Haemorrhage—Doxorubicin—breast cancer	3.62e-05	0.00015	CcSEcCtD
Entacapone—COMT—Metabolism—BCHE—breast cancer	3.62e-05	0.00037	CbGpPWpGaD
Entacapone—Insomnia—Capecitabine—breast cancer	3.61e-05	0.000149	CcSEcCtD
Entacapone—Hypoaesthesia—Doxorubicin—breast cancer	3.61e-05	0.000149	CcSEcCtD
Entacapone—Rash—Fluorouracil—breast cancer	3.6e-05	0.000149	CcSEcCtD
Entacapone—Dermatitis—Fluorouracil—breast cancer	3.6e-05	0.000149	CcSEcCtD
Entacapone—Pharyngitis—Doxorubicin—breast cancer	3.6e-05	0.000149	CcSEcCtD
Entacapone—Paraesthesia—Capecitabine—breast cancer	3.59e-05	0.000148	CcSEcCtD
Entacapone—Decreased appetite—Docetaxel—breast cancer	3.59e-05	0.000148	CcSEcCtD
Entacapone—Hypersensitivity—Paclitaxel—breast cancer	3.59e-05	0.000148	CcSEcCtD
Entacapone—Headache—Fluorouracil—breast cancer	3.58e-05	0.000148	CcSEcCtD
Entacapone—Urinary tract disorder—Doxorubicin—breast cancer	3.58e-05	0.000148	CcSEcCtD
Entacapone—COMT—Metabolism—SLC5A5—breast cancer	3.57e-05	0.000365	CbGpPWpGaD
Entacapone—Dysgeusia—Methotrexate—breast cancer	3.57e-05	0.000148	CcSEcCtD
Entacapone—Gastrointestinal disorder—Docetaxel—breast cancer	3.56e-05	0.000147	CcSEcCtD
Entacapone—Dyspnoea—Capecitabine—breast cancer	3.56e-05	0.000147	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	3.56e-05	0.000364	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	3.56e-05	0.000364	CbGpPWpGaD
Entacapone—Fatigue—Docetaxel—breast cancer	3.56e-05	0.000147	CcSEcCtD
Entacapone—Urethral disorder—Doxorubicin—breast cancer	3.55e-05	0.000147	CcSEcCtD
Entacapone—Nausea—Irinotecan—breast cancer	3.55e-05	0.000147	CcSEcCtD
Entacapone—Nausea—Mitoxantrone—breast cancer	3.55e-05	0.000147	CcSEcCtD
Entacapone—Constipation—Docetaxel—breast cancer	3.53e-05	0.000146	CcSEcCtD
Entacapone—Pain—Docetaxel—breast cancer	3.53e-05	0.000146	CcSEcCtD
Entacapone—Back pain—Methotrexate—breast cancer	3.52e-05	0.000146	CcSEcCtD
Entacapone—Dyspepsia—Capecitabine—breast cancer	3.52e-05	0.000145	CcSEcCtD
Entacapone—Visual impairment—Doxorubicin—breast cancer	3.49e-05	0.000144	CcSEcCtD
Entacapone—Asthenia—Paclitaxel—breast cancer	3.49e-05	0.000144	CcSEcCtD
Entacapone—Decreased appetite—Capecitabine—breast cancer	3.47e-05	0.000144	CcSEcCtD
Entacapone—Alopecia—Epirubicin—breast cancer	3.46e-05	0.000143	CcSEcCtD
Entacapone—Nausea—Gemcitabine—breast cancer	3.45e-05	0.000143	CcSEcCtD
Entacapone—COMT—Metabolism—SLC2A1—breast cancer	3.45e-05	0.000353	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA4—breast cancer	3.45e-05	0.000353	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CA9—breast cancer	3.45e-05	0.000353	CbGpPWpGaD
Entacapone—COMT—Metabolism—NQO1—breast cancer	3.45e-05	0.000353	CbGpPWpGaD
Entacapone—Gastrointestinal disorder—Capecitabine—breast cancer	3.45e-05	0.000143	CcSEcCtD
Entacapone—Fatigue—Capecitabine—breast cancer	3.44e-05	0.000142	CcSEcCtD
Entacapone—Pruritus—Paclitaxel—breast cancer	3.44e-05	0.000142	CcSEcCtD
Entacapone—Vision blurred—Methotrexate—breast cancer	3.43e-05	0.000142	CcSEcCtD
Entacapone—Mental disorder—Epirubicin—breast cancer	3.43e-05	0.000142	CcSEcCtD
Entacapone—Erythema multiforme—Doxorubicin—breast cancer	3.43e-05	0.000142	CcSEcCtD
Entacapone—Pain—Capecitabine—breast cancer	3.42e-05	0.000141	CcSEcCtD
Entacapone—Constipation—Capecitabine—breast cancer	3.42e-05	0.000141	CcSEcCtD
Entacapone—Malnutrition—Epirubicin—breast cancer	3.41e-05	0.000141	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.41e-05	0.000348	CbGpPWpGaD
Entacapone—Feeling abnormal—Docetaxel—breast cancer	3.4e-05	0.000141	CcSEcCtD
Entacapone—Nausea—Fluorouracil—breast cancer	3.4e-05	0.00014	CcSEcCtD
Entacapone—Eye disorder—Doxorubicin—breast cancer	3.39e-05	0.00014	CcSEcCtD
Entacapone—Ill-defined disorder—Methotrexate—breast cancer	3.38e-05	0.00014	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.37e-05	0.000345	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Docetaxel—breast cancer	3.37e-05	0.00014	CcSEcCtD
Entacapone—COMT—Neuronal System—HRAS—breast cancer	3.37e-05	0.000344	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP3A4—breast cancer	3.37e-05	0.000344	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTA2—breast cancer	3.36e-05	0.000344	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPX2—breast cancer	3.36e-05	0.000344	CbGpPWpGaD
Entacapone—Flushing—Doxorubicin—breast cancer	3.36e-05	0.000139	CcSEcCtD
Entacapone—Cardiac disorder—Doxorubicin—breast cancer	3.36e-05	0.000139	CcSEcCtD
Entacapone—Flatulence—Epirubicin—breast cancer	3.36e-05	0.000139	CcSEcCtD
Entacapone—Tension—Epirubicin—breast cancer	3.35e-05	0.000138	CcSEcCtD
Entacapone—Dysgeusia—Epirubicin—breast cancer	3.34e-05	0.000138	CcSEcCtD
Entacapone—Diarrhoea—Paclitaxel—breast cancer	3.33e-05	0.000138	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SULT1A1—breast cancer	3.32e-05	0.00034	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GPX4—breast cancer	3.32e-05	0.00034	CbGpPWpGaD
Entacapone—Nervousness—Epirubicin—breast cancer	3.31e-05	0.000137	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1B1—breast cancer	3.31e-05	0.000338	CbGpPWpGaD
Entacapone—Back pain—Epirubicin—breast cancer	3.3e-05	0.000136	CcSEcCtD
Entacapone—Feeling abnormal—Capecitabine—breast cancer	3.29e-05	0.000136	CcSEcCtD
Entacapone—Malaise—Methotrexate—breast cancer	3.29e-05	0.000136	CcSEcCtD
Entacapone—Muscle spasms—Epirubicin—breast cancer	3.28e-05	0.000136	CcSEcCtD
Entacapone—Vertigo—Methotrexate—breast cancer	3.27e-05	0.000135	CcSEcCtD
Entacapone—Gastrointestinal pain—Capecitabine—breast cancer	3.27e-05	0.000135	CcSEcCtD
Entacapone—Body temperature increased—Docetaxel—breast cancer	3.26e-05	0.000135	CcSEcCtD
Entacapone—Abdominal pain—Docetaxel—breast cancer	3.26e-05	0.000135	CcSEcCtD
Entacapone—Leukopenia—Methotrexate—breast cancer	3.26e-05	0.000135	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GSTA1—breast cancer	3.25e-05	0.000332	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—IDH1—breast cancer	3.25e-05	0.000332	CbGpPWpGaD
Entacapone—COMT—Metabolism—HSP90AA1—breast cancer	3.25e-05	0.000332	CbGpPWpGaD
Entacapone—Dizziness—Paclitaxel—breast cancer	3.22e-05	0.000133	CcSEcCtD
Entacapone—Vision blurred—Epirubicin—breast cancer	3.21e-05	0.000133	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NAT2—breast cancer	3.21e-05	0.000328	CbGpPWpGaD
Entacapone—Alopecia—Doxorubicin—breast cancer	3.2e-05	0.000132	CcSEcCtD
Entacapone—Cough—Methotrexate—breast cancer	3.18e-05	0.000132	CcSEcCtD
Entacapone—Mental disorder—Doxorubicin—breast cancer	3.18e-05	0.000131	CcSEcCtD
Entacapone—Urticaria—Capecitabine—breast cancer	3.17e-05	0.000131	CcSEcCtD
Entacapone—Ill-defined disorder—Epirubicin—breast cancer	3.16e-05	0.000131	CcSEcCtD
Entacapone—Body temperature increased—Capecitabine—breast cancer	3.16e-05	0.000131	CcSEcCtD
Entacapone—Abdominal pain—Capecitabine—breast cancer	3.16e-05	0.000131	CcSEcCtD
Entacapone—COMT—Metabolism—NCOA1—breast cancer	3.16e-05	0.000323	CbGpPWpGaD
Entacapone—Convulsion—Methotrexate—breast cancer	3.16e-05	0.000131	CcSEcCtD
Entacapone—Malnutrition—Doxorubicin—breast cancer	3.16e-05	0.000131	CcSEcCtD
Entacapone—Agitation—Epirubicin—breast cancer	3.13e-05	0.00013	CcSEcCtD
Entacapone—COMT—Metabolism—STK11—breast cancer	3.11e-05	0.000318	CbGpPWpGaD
Entacapone—COMT—Metabolism—CYP19A1—breast cancer	3.11e-05	0.000318	CbGpPWpGaD
Entacapone—Flatulence—Doxorubicin—breast cancer	3.11e-05	0.000129	CcSEcCtD
Entacapone—Chest pain—Methotrexate—breast cancer	3.1e-05	0.000128	CcSEcCtD
Entacapone—Myalgia—Methotrexate—breast cancer	3.1e-05	0.000128	CcSEcCtD
Entacapone—Tension—Doxorubicin—breast cancer	3.1e-05	0.000128	CcSEcCtD
Entacapone—Vomiting—Paclitaxel—breast cancer	3.09e-05	0.000128	CcSEcCtD
Entacapone—Dysgeusia—Doxorubicin—breast cancer	3.09e-05	0.000128	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	3.08e-05	0.000127	CcSEcCtD
Entacapone—Malaise—Epirubicin—breast cancer	3.07e-05	0.000127	CcSEcCtD
Entacapone—Rash—Paclitaxel—breast cancer	3.07e-05	0.000127	CcSEcCtD
Entacapone—Dermatitis—Paclitaxel—breast cancer	3.07e-05	0.000127	CcSEcCtD
Entacapone—Discomfort—Methotrexate—breast cancer	3.06e-05	0.000127	CcSEcCtD
Entacapone—Nervousness—Doxorubicin—breast cancer	3.06e-05	0.000127	CcSEcCtD
Entacapone—Vertigo—Epirubicin—breast cancer	3.06e-05	0.000127	CcSEcCtD
Entacapone—Syncope—Epirubicin—breast cancer	3.06e-05	0.000126	CcSEcCtD
Entacapone—Leukopenia—Epirubicin—breast cancer	3.05e-05	0.000126	CcSEcCtD
Entacapone—Back pain—Doxorubicin—breast cancer	3.05e-05	0.000126	CcSEcCtD
Entacapone—Headache—Paclitaxel—breast cancer	3.05e-05	0.000126	CcSEcCtD
Entacapone—Hypersensitivity—Docetaxel—breast cancer	3.04e-05	0.000126	CcSEcCtD
Entacapone—Muscle spasms—Doxorubicin—breast cancer	3.03e-05	0.000125	CcSEcCtD
Entacapone—Palpitations—Epirubicin—breast cancer	3.01e-05	0.000125	CcSEcCtD
Entacapone—Confusional state—Methotrexate—breast cancer	3e-05	0.000124	CcSEcCtD
Entacapone—Loss of consciousness—Epirubicin—breast cancer	3e-05	0.000124	CcSEcCtD
Entacapone—Cough—Epirubicin—breast cancer	2.98e-05	0.000123	CcSEcCtD
Entacapone—Vision blurred—Doxorubicin—breast cancer	2.97e-05	0.000123	CcSEcCtD
Entacapone—Asthenia—Docetaxel—breast cancer	2.96e-05	0.000122	CcSEcCtD
Entacapone—Convulsion—Epirubicin—breast cancer	2.95e-05	0.000122	CcSEcCtD
Entacapone—Hypertension—Epirubicin—breast cancer	2.94e-05	0.000122	CcSEcCtD
Entacapone—Hypersensitivity—Capecitabine—breast cancer	2.94e-05	0.000122	CcSEcCtD
Entacapone—Ill-defined disorder—Doxorubicin—breast cancer	2.93e-05	0.000121	CcSEcCtD
Entacapone—Pruritus—Docetaxel—breast cancer	2.92e-05	0.000121	CcSEcCtD
Entacapone—Nervous system disorder—Methotrexate—breast cancer	2.92e-05	0.000121	CcSEcCtD
Entacapone—Thrombocytopenia—Methotrexate—breast cancer	2.91e-05	0.00012	CcSEcCtD
Entacapone—Myalgia—Epirubicin—breast cancer	2.9e-05	0.00012	CcSEcCtD
Entacapone—Chest pain—Epirubicin—breast cancer	2.9e-05	0.00012	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—breast cancer	2.9e-05	0.000296	CbGpPWpGaD
Entacapone—Agitation—Doxorubicin—breast cancer	2.9e-05	0.00012	CcSEcCtD
Entacapone—Anxiety—Epirubicin—breast cancer	2.89e-05	0.00012	CcSEcCtD
Entacapone—Nausea—Paclitaxel—breast cancer	2.89e-05	0.00012	CcSEcCtD
Entacapone—Skin disorder—Methotrexate—breast cancer	2.89e-05	0.000119	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.88e-05	0.000119	CcSEcCtD
Entacapone—COMT—Metabolism—GSTP1—breast cancer	2.88e-05	0.000294	CbGpPWpGaD
Entacapone—Hyperhidrosis—Methotrexate—breast cancer	2.87e-05	0.000119	CcSEcCtD
Entacapone—Discomfort—Epirubicin—breast cancer	2.87e-05	0.000119	CcSEcCtD
Entacapone—Asthenia—Capecitabine—breast cancer	2.87e-05	0.000119	CcSEcCtD
Entacapone—Malaise—Doxorubicin—breast cancer	2.85e-05	0.000118	CcSEcCtD
Entacapone—COMT—Metabolism—HMOX1—breast cancer	2.84e-05	0.00029	CbGpPWpGaD
Entacapone—Dry mouth—Epirubicin—breast cancer	2.84e-05	0.000117	CcSEcCtD
Entacapone—Vertigo—Doxorubicin—breast cancer	2.83e-05	0.000117	CcSEcCtD
Entacapone—Anorexia—Methotrexate—breast cancer	2.83e-05	0.000117	CcSEcCtD
Entacapone—COMT—Metabolism—ITPR1—breast cancer	2.83e-05	0.000289	CbGpPWpGaD
Entacapone—Syncope—Doxorubicin—breast cancer	2.83e-05	0.000117	CcSEcCtD
Entacapone—Pruritus—Capecitabine—breast cancer	2.83e-05	0.000117	CcSEcCtD
Entacapone—Leukopenia—Doxorubicin—breast cancer	2.82e-05	0.000117	CcSEcCtD
Entacapone—Diarrhoea—Docetaxel—breast cancer	2.82e-05	0.000117	CcSEcCtD
Entacapone—UGT1A9—Metabolism—DPYD—breast cancer	2.81e-05	0.000288	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MED12—breast cancer	2.81e-05	0.000288	CbGpPWpGaD
Entacapone—Confusional state—Epirubicin—breast cancer	2.81e-05	0.000116	CcSEcCtD
Entacapone—Palpitations—Doxorubicin—breast cancer	2.79e-05	0.000115	CcSEcCtD
Entacapone—Oedema—Epirubicin—breast cancer	2.78e-05	0.000115	CcSEcCtD
Entacapone—Hypotension—Methotrexate—breast cancer	2.78e-05	0.000115	CcSEcCtD
Entacapone—Loss of consciousness—Doxorubicin—breast cancer	2.77e-05	0.000115	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ALDOA—breast cancer	2.77e-05	0.000283	CbGpPWpGaD
Entacapone—Cough—Doxorubicin—breast cancer	2.75e-05	0.000114	CcSEcCtD
Entacapone—Shock—Epirubicin—breast cancer	2.74e-05	0.000113	CcSEcCtD
Entacapone—Convulsion—Doxorubicin—breast cancer	2.73e-05	0.000113	CcSEcCtD
Entacapone—Diarrhoea—Capecitabine—breast cancer	2.73e-05	0.000113	CcSEcCtD
Entacapone—Nervous system disorder—Epirubicin—breast cancer	2.73e-05	0.000113	CcSEcCtD
Entacapone—Dizziness—Docetaxel—breast cancer	2.73e-05	0.000113	CcSEcCtD
Entacapone—COMT—Metabolism—ABCB1—breast cancer	2.73e-05	0.000278	CbGpPWpGaD
Entacapone—Thrombocytopenia—Epirubicin—breast cancer	2.72e-05	0.000113	CcSEcCtD
Entacapone—Hypertension—Doxorubicin—breast cancer	2.72e-05	0.000113	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Methotrexate—breast cancer	2.71e-05	0.000112	CcSEcCtD
Entacapone—Skin disorder—Epirubicin—breast cancer	2.7e-05	0.000112	CcSEcCtD
Entacapone—Hyperhidrosis—Epirubicin—breast cancer	2.69e-05	0.000111	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA3—breast cancer	2.69e-05	0.000275	CbGpPWpGaD
Entacapone—Insomnia—Methotrexate—breast cancer	2.69e-05	0.000111	CcSEcCtD
Entacapone—Myalgia—Doxorubicin—breast cancer	2.69e-05	0.000111	CcSEcCtD
Entacapone—Chest pain—Doxorubicin—breast cancer	2.69e-05	0.000111	CcSEcCtD
Entacapone—COMT—Metabolism—TYMS—breast cancer	2.68e-05	0.000273	CbGpPWpGaD
Entacapone—Anxiety—Doxorubicin—breast cancer	2.68e-05	0.000111	CcSEcCtD
Entacapone—UGT1A9—Metabolism—SLC2A2—breast cancer	2.67e-05	0.000273	CbGpPWpGaD
Entacapone—Paraesthesia—Methotrexate—breast cancer	2.67e-05	0.00011	CcSEcCtD
Entacapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	2.67e-05	0.00011	CcSEcCtD
Entacapone—Discomfort—Doxorubicin—breast cancer	2.65e-05	0.00011	CcSEcCtD
Entacapone—Anorexia—Epirubicin—breast cancer	2.65e-05	0.00011	CcSEcCtD
Entacapone—Dyspnoea—Methotrexate—breast cancer	2.65e-05	0.00011	CcSEcCtD
Entacapone—COMT—Metabolism—PLA2G4A—breast cancer	2.65e-05	0.00027	CbGpPWpGaD
Entacapone—COMT—Metabolism—NCOR1—breast cancer	2.65e-05	0.00027	CbGpPWpGaD
Entacapone—COMT—Metabolism—GSTM1—breast cancer	2.65e-05	0.00027	CbGpPWpGaD
Entacapone—Somnolence—Methotrexate—breast cancer	2.64e-05	0.000109	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.64e-05	0.00027	CbGpPWpGaD
Entacapone—Dizziness—Capecitabine—breast cancer	2.64e-05	0.000109	CcSEcCtD
Entacapone—Dry mouth—Doxorubicin—breast cancer	2.63e-05	0.000109	CcSEcCtD
Entacapone—Vomiting—Docetaxel—breast cancer	2.62e-05	0.000109	CcSEcCtD
Entacapone—Dyspepsia—Methotrexate—breast cancer	2.62e-05	0.000108	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ABCG2—breast cancer	2.62e-05	0.000267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTR—breast cancer	2.62e-05	0.000267	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CPT1A—breast cancer	2.62e-05	0.000267	CbGpPWpGaD
Entacapone—Rash—Docetaxel—breast cancer	2.6e-05	0.000108	CcSEcCtD
Entacapone—Hypotension—Epirubicin—breast cancer	2.6e-05	0.000108	CcSEcCtD
Entacapone—Dermatitis—Docetaxel—breast cancer	2.6e-05	0.000108	CcSEcCtD
Entacapone—Confusional state—Doxorubicin—breast cancer	2.6e-05	0.000107	CcSEcCtD
Entacapone—Decreased appetite—Methotrexate—breast cancer	2.59e-05	0.000107	CcSEcCtD
Entacapone—Headache—Docetaxel—breast cancer	2.58e-05	0.000107	CcSEcCtD
Entacapone—Oedema—Doxorubicin—breast cancer	2.57e-05	0.000107	CcSEcCtD
Entacapone—Gastrointestinal disorder—Methotrexate—breast cancer	2.57e-05	0.000106	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HPGDS—breast cancer	2.57e-05	0.000262	CbGpPWpGaD
Entacapone—Fatigue—Methotrexate—breast cancer	2.56e-05	0.000106	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HBA1—breast cancer	2.55e-05	0.00026	CbGpPWpGaD
Entacapone—Pain—Methotrexate—breast cancer	2.54e-05	0.000105	CcSEcCtD
Entacapone—Vomiting—Capecitabine—breast cancer	2.54e-05	0.000105	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.54e-05	0.000105	CcSEcCtD
Entacapone—COMT—Metabolism—GPX1—breast cancer	2.53e-05	0.000259	CbGpPWpGaD
Entacapone—Shock—Doxorubicin—breast cancer	2.53e-05	0.000105	CcSEcCtD
Entacapone—Nervous system disorder—Doxorubicin—breast cancer	2.53e-05	0.000104	CcSEcCtD
Entacapone—Thrombocytopenia—Doxorubicin—breast cancer	2.52e-05	0.000104	CcSEcCtD
Entacapone—Rash—Capecitabine—breast cancer	2.52e-05	0.000104	CcSEcCtD
Entacapone—Insomnia—Epirubicin—breast cancer	2.52e-05	0.000104	CcSEcCtD
Entacapone—Dermatitis—Capecitabine—breast cancer	2.52e-05	0.000104	CcSEcCtD
Entacapone—COMT—Metabolism—CYP1A1—breast cancer	2.51e-05	0.000256	CbGpPWpGaD
Entacapone—Headache—Capecitabine—breast cancer	2.5e-05	0.000104	CcSEcCtD
Entacapone—Skin disorder—Doxorubicin—breast cancer	2.5e-05	0.000103	CcSEcCtD
Entacapone—Paraesthesia—Epirubicin—breast cancer	2.5e-05	0.000103	CcSEcCtD
Entacapone—Hyperhidrosis—Doxorubicin—breast cancer	2.49e-05	0.000103	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ACHE—breast cancer	2.49e-05	0.000254	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTT1—breast cancer	2.49e-05	0.000254	CbGpPWpGaD
Entacapone—COMT—Metabolism—ERCC2—breast cancer	2.49e-05	0.000254	CbGpPWpGaD
Entacapone—Dyspnoea—Epirubicin—breast cancer	2.48e-05	0.000103	CcSEcCtD
Entacapone—Somnolence—Epirubicin—breast cancer	2.47e-05	0.000102	CcSEcCtD
Entacapone—Anorexia—Doxorubicin—breast cancer	2.45e-05	0.000102	CcSEcCtD
Entacapone—Nausea—Docetaxel—breast cancer	2.45e-05	0.000101	CcSEcCtD
Entacapone—Feeling abnormal—Methotrexate—breast cancer	2.45e-05	0.000101	CcSEcCtD
Entacapone—Dyspepsia—Epirubicin—breast cancer	2.45e-05	0.000101	CcSEcCtD
Entacapone—Gastrointestinal pain—Methotrexate—breast cancer	2.43e-05	0.000101	CcSEcCtD
Entacapone—Decreased appetite—Epirubicin—breast cancer	2.42e-05	0.0001	CcSEcCtD
Entacapone—Hypotension—Doxorubicin—breast cancer	2.41e-05	9.95e-05	CcSEcCtD
Entacapone—Gastrointestinal disorder—Epirubicin—breast cancer	2.4e-05	9.94e-05	CcSEcCtD
Entacapone—Fatigue—Epirubicin—breast cancer	2.4e-05	9.93e-05	CcSEcCtD
Entacapone—Pain—Epirubicin—breast cancer	2.38e-05	9.84e-05	CcSEcCtD
Entacapone—Constipation—Epirubicin—breast cancer	2.38e-05	9.84e-05	CcSEcCtD
Entacapone—Nausea—Capecitabine—breast cancer	2.37e-05	9.82e-05	CcSEcCtD
Entacapone—Urticaria—Methotrexate—breast cancer	2.36e-05	9.77e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP17A1—breast cancer	2.36e-05	0.000241	CbGpPWpGaD
Entacapone—Abdominal pain—Methotrexate—breast cancer	2.35e-05	9.72e-05	CcSEcCtD
Entacapone—Body temperature increased—Methotrexate—breast cancer	2.35e-05	9.72e-05	CcSEcCtD
Entacapone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.35e-05	9.7e-05	CcSEcCtD
Entacapone—COMT—Metabolism—MTHFR—breast cancer	2.34e-05	0.000239	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS1—breast cancer	2.33e-05	0.000238	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ENO1—breast cancer	2.33e-05	0.000238	CbGpPWpGaD
Entacapone—Insomnia—Doxorubicin—breast cancer	2.33e-05	9.63e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.32e-05	0.000237	CbGpPWpGaD
Entacapone—Paraesthesia—Doxorubicin—breast cancer	2.31e-05	9.56e-05	CcSEcCtD
Entacapone—Dyspnoea—Doxorubicin—breast cancer	2.3e-05	9.5e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.29e-05	0.000234	CbGpPWpGaD
Entacapone—Feeling abnormal—Epirubicin—breast cancer	2.29e-05	9.49e-05	CcSEcCtD
Entacapone—Somnolence—Doxorubicin—breast cancer	2.29e-05	9.47e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP2D6—breast cancer	2.29e-05	0.000234	CbGpPWpGaD
Entacapone—Gastrointestinal pain—Epirubicin—breast cancer	2.28e-05	9.41e-05	CcSEcCtD
Entacapone—Dyspepsia—Doxorubicin—breast cancer	2.27e-05	9.38e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA2—breast cancer	2.24e-05	0.000229	CbGpPWpGaD
Entacapone—Decreased appetite—Doxorubicin—breast cancer	2.24e-05	9.26e-05	CcSEcCtD
Entacapone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.22e-05	9.2e-05	CcSEcCtD
Entacapone—Fatigue—Doxorubicin—breast cancer	2.22e-05	9.18e-05	CcSEcCtD
Entacapone—Urticaria—Epirubicin—breast cancer	2.21e-05	9.15e-05	CcSEcCtD
Entacapone—Constipation—Doxorubicin—breast cancer	2.2e-05	9.11e-05	CcSEcCtD
Entacapone—Pain—Doxorubicin—breast cancer	2.2e-05	9.11e-05	CcSEcCtD
Entacapone—Abdominal pain—Epirubicin—breast cancer	2.2e-05	9.1e-05	CcSEcCtD
Entacapone—Body temperature increased—Epirubicin—breast cancer	2.2e-05	9.1e-05	CcSEcCtD
Entacapone—Hypersensitivity—Methotrexate—breast cancer	2.19e-05	9.06e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—FASN—breast cancer	2.18e-05	0.000222	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—BCHE—breast cancer	2.17e-05	0.000221	CbGpPWpGaD
Entacapone—COMT—Metabolism—CAV1—breast cancer	2.16e-05	0.00022	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC5A5—breast cancer	2.14e-05	0.000219	CbGpPWpGaD
Entacapone—Asthenia—Methotrexate—breast cancer	2.13e-05	8.83e-05	CcSEcCtD
Entacapone—Feeling abnormal—Doxorubicin—breast cancer	2.12e-05	8.78e-05	CcSEcCtD
Entacapone—Gastrointestinal pain—Doxorubicin—breast cancer	2.11e-05	8.71e-05	CcSEcCtD
Entacapone—Pruritus—Methotrexate—breast cancer	2.1e-05	8.7e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NQO1—breast cancer	2.07e-05	0.000211	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—SLC2A1—breast cancer	2.07e-05	0.000211	CbGpPWpGaD
Entacapone—Hypersensitivity—Epirubicin—breast cancer	2.05e-05	8.48e-05	CcSEcCtD
Entacapone—Urticaria—Doxorubicin—breast cancer	2.05e-05	8.46e-05	CcSEcCtD
Entacapone—Body temperature increased—Doxorubicin—breast cancer	2.04e-05	8.42e-05	CcSEcCtD
Entacapone—Abdominal pain—Doxorubicin—breast cancer	2.04e-05	8.42e-05	CcSEcCtD
Entacapone—Diarrhoea—Methotrexate—breast cancer	2.03e-05	8.42e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.03e-05	0.000207	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP3A4—breast cancer	2.02e-05	0.000206	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.01e-05	0.000205	CbGpPWpGaD
Entacapone—Asthenia—Epirubicin—breast cancer	2e-05	8.26e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP1B1—breast cancer	1.98e-05	0.000203	CbGpPWpGaD
Entacapone—Pruritus—Epirubicin—breast cancer	1.97e-05	8.14e-05	CcSEcCtD
Entacapone—Dizziness—Methotrexate—breast cancer	1.97e-05	8.13e-05	CcSEcCtD
Entacapone—COMT—Metabolism—PIK3CG—breast cancer	1.96e-05	0.000201	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—HSP90AA1—breast cancer	1.94e-05	0.000199	CbGpPWpGaD
Entacapone—Diarrhoea—Epirubicin—breast cancer	1.9e-05	7.88e-05	CcSEcCtD
Entacapone—Hypersensitivity—Doxorubicin—breast cancer	1.9e-05	7.85e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—NCOA1—breast cancer	1.89e-05	0.000193	CbGpPWpGaD
Entacapone—Vomiting—Methotrexate—breast cancer	1.89e-05	7.82e-05	CcSEcCtD
Entacapone—Rash—Methotrexate—breast cancer	1.87e-05	7.76e-05	CcSEcCtD
Entacapone—Dermatitis—Methotrexate—breast cancer	1.87e-05	7.75e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—CYP19A1—breast cancer	1.86e-05	0.00019	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—STK11—breast cancer	1.86e-05	0.00019	CbGpPWpGaD
Entacapone—Headache—Methotrexate—breast cancer	1.86e-05	7.71e-05	CcSEcCtD
Entacapone—Asthenia—Doxorubicin—breast cancer	1.85e-05	7.64e-05	CcSEcCtD
Entacapone—Dizziness—Epirubicin—breast cancer	1.84e-05	7.61e-05	CcSEcCtD
Entacapone—Pruritus—Doxorubicin—breast cancer	1.82e-05	7.54e-05	CcSEcCtD
Entacapone—Vomiting—Epirubicin—breast cancer	1.77e-05	7.32e-05	CcSEcCtD
Entacapone—Nausea—Methotrexate—breast cancer	1.77e-05	7.31e-05	CcSEcCtD
Entacapone—Diarrhoea—Doxorubicin—breast cancer	1.76e-05	7.29e-05	CcSEcCtD
Entacapone—Rash—Epirubicin—breast cancer	1.75e-05	7.26e-05	CcSEcCtD
Entacapone—Dermatitis—Epirubicin—breast cancer	1.75e-05	7.25e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.75e-05	0.000179	CbGpPWpGaD
Entacapone—Headache—Epirubicin—breast cancer	1.74e-05	7.21e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—COMT—breast cancer	1.73e-05	0.000177	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CD—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTP1—breast cancer	1.73e-05	0.000176	CbGpPWpGaD
Entacapone—COMT—Metabolism—ALB—breast cancer	1.71e-05	0.000174	CbGpPWpGaD
Entacapone—Dizziness—Doxorubicin—breast cancer	1.7e-05	7.04e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—HMOX1—breast cancer	1.7e-05	0.000174	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ITPR1—breast cancer	1.7e-05	0.000173	CbGpPWpGaD
Entacapone—Nausea—Epirubicin—breast cancer	1.65e-05	6.84e-05	CcSEcCtD
Entacapone—Vomiting—Doxorubicin—breast cancer	1.64e-05	6.77e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—ABCB1—breast cancer	1.63e-05	0.000167	CbGpPWpGaD
Entacapone—COMT—Metabolism—NOS3—breast cancer	1.63e-05	0.000167	CbGpPWpGaD
Entacapone—Rash—Doxorubicin—breast cancer	1.62e-05	6.72e-05	CcSEcCtD
Entacapone—Dermatitis—Doxorubicin—breast cancer	1.62e-05	6.71e-05	CcSEcCtD
Entacapone—Headache—Doxorubicin—breast cancer	1.61e-05	6.67e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—TYMS—breast cancer	1.6e-05	0.000164	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PLA2G4A—breast cancer	1.59e-05	0.000162	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NCOR1—breast cancer	1.59e-05	0.000162	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—GSTM1—breast cancer	1.59e-05	0.000162	CbGpPWpGaD
Entacapone—Nausea—Doxorubicin—breast cancer	1.53e-05	6.33e-05	CcSEcCtD
Entacapone—UGT1A9—Metabolism—GPX1—breast cancer	1.52e-05	0.000155	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CB—breast cancer	1.51e-05	0.000154	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CYP1A1—breast cancer	1.5e-05	0.000154	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTGS2—breast cancer	1.49e-05	0.000152	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ERCC2—breast cancer	1.49e-05	0.000152	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—MTHFR—breast cancer	1.4e-05	0.000143	CbGpPWpGaD
Entacapone—COMT—Metabolism—PTEN—breast cancer	1.3e-05	0.000133	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—CAV1—breast cancer	1.29e-05	0.000132	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.23e-05	0.000126	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CG—breast cancer	1.18e-05	0.00012	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CD—breast cancer	1.03e-05	0.000106	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—ALB—breast cancer	1.02e-05	0.000104	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—NOS3—breast cancer	9.77e-06	9.98e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—PIK3CA—breast cancer	9.18e-06	9.38e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CB—breast cancer	9.02e-06	9.21e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTGS2—breast cancer	8.94e-06	9.13e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PTEN—breast cancer	7.79e-06	7.96e-05	CbGpPWpGaD
Entacapone—COMT—Metabolism—AKT1—breast cancer	7.5e-06	7.66e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—PIK3CA—breast cancer	5.5e-06	5.62e-05	CbGpPWpGaD
Entacapone—UGT1A9—Metabolism—AKT1—breast cancer	4.49e-06	4.59e-05	CbGpPWpGaD
